Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05968300 · ClinicalTrials.gov registry record · NA

Getting INFORMED and Living Well Among Asian Americans in California

A NA study of COVID-19 and Well-Being, Psychological, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
616
Enrollment target
4
Study locations

NCT05968300: Completed NA study of COVID-19 and Well-Being, Psychological, sponsored by University of California, San Francisco.

NCT05968300 is a NA study of COVID-19 and Well-Being, Psychological that has completed, run by University of California, San Francisco. The registered enrollment target is 616 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05968300, a NA study of COVID-19 and Well-Being, Psychological, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
616 participants
Enrollment target
4
Study locations

Study Summary

The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians. The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in California who speak/read English, Chinese, Korean, Hmong, or Vietnamese.

Primary Outcome

Self-assessed perceptions of decision conflict will be assessed using the 4-item Decision Conflict Scale (SURE). Scores on the SURE scale range from 0 to 4, with higher scores indicating less decisional conflict. A score of less than 4 indicates decisional conflict.

Interventions

  • BEHAVIORAL Text Messaging Only
  • BEHAVIORAL INFORMED-Living Well

Study Locations (4)

California

  • The Fresno Center - Fresno
  • Chinese Community Health Resource Center - San Francisco
  • University of California, San Francisco - San Francisco
  • Immigrant Resettlement & Cultural Center - San Jose

Trial Details

FieldValue
Enrollment Target 616 participants
Start Date 2024-03-20
Est. Completion 2024-08-31
Phase NA

What the finished NCT05968300 record still lists

NCT05968300 is an interventional study that assigns participants to a tested intervention. The registered 616 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging Only is the first listed.

NCT05968300 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05968300 about?

NCT05968300 is a clinical study titled "Getting INFORMED and Living Well Among Asian Americans in California". The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians. The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in Cal...

What is the current status of trial NCT05968300?

This trial is currently completed. It is a NA study. The enrollment target is 616 participants. The study started on 2024-03-20. Estimated completion is 2024-08-31.

What conditions does trial NCT05968300 study?

This clinical trial studies the following conditions: COVID-19, Well-Being, Psychological.

What interventions are being tested in trial NCT05968300?

The interventions under investigation include: Text Messaging Only (BEHAVIORAL), INFORMED-Living Well (BEHAVIORAL).

Who is sponsoring clinical trial NCT05968300?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05968300 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05968300's enrollment target sits among peer trials

616 98th of 298 higher than 201 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04813185 · 616 participants · NA

    Preventing Retaliatory Gun Violence in Violently Injured Adults

  • NCT06105957 · 616 participants · NA

    Optimal Digital Weight Loss Treatment for Rural Individuals

  • NCT06162221 · 616 participants · Phase 1

    Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • NCT02610179 · 617 participants · NA

    Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05968300, the US trial registry maintained by the National Library of Medicine. NCT05968300 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.